IQVIA Scribe vs YPrime
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IQVIA Scribe
This application allows patients participating in clinical trials to securely capture and submit data directly from their devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.
- Patient data capture
- Online/offline functionality
- Clinical trial questionnaires
- Secure data submission
- Automated eCOA process
Read full descriptionHide full description
IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.
YPrime
Manage your clinical study tasks conveniently from your personal device. Log in using your enrollment ID to complete training and stay connected to your study activities, fitting them into your daily schedule.
- Log in and review study tasks
- Complete clinical study activities
- Manage tasks at your own pace
- Stay connected to your study
- Use on personal devices
Read full descriptionHide full description
Log in, review, and finish clinical study activities at places and times that fit your daily lifestyle. Download this app on your personal device. Use the enrollment ID provided by your healthcare provider to create your unique login code, then finish your training. Stay connected to your clinical study by using YPrime. This app is only available to those taking part in a sponsored clinical study.
Screenshots
Verdict
The clearest difference is rating: YPrime at 5.0 against IQVIA Scribe's 2.9. YPrime also leads on review sentiment (50% vs 19%) and update cadence (every 3 weeks vs every 2 months). IQVIA Scribe's advantage is ratings volume (38 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
YPrime holds the better App Store score, 5.0 against 2.9. That said, the two scores are not equally well evidenced: IQVIA Scribe has 38 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 19% of IQVIA Scribe's written reviews are positive against 50% of YPrime's.
IQVIA Scribe ships an update every 2 months, YPrime every 3 weeks. The most recent releases landed on November 11, 2026 and November 3, 2026 respectively.
| Parameter | IQVIA Scribe | YPrime |
|---|---|---|
| Price | Free | Free |
| Rating | 2.9 (38 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 19.0% of reviews | 50.0% of reviews — better |
| Number of ratings | 38 — better | 1 |
| Update frequency | Every 2 months | Every 3 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.5 | 15.0 — better |
| Further details — not scored | ||
| Size | 33 MB | 110 MB |
| Age rating | 4+ | 4+ |
| Developer | IQVIA RDS INC. | Y-Prime |
Customer experience
IQVIA Scribe
YPrime
In-app purchases
IQVIA Scribe
No in-app purchases
YPrime
No in-app purchases
